Cardiac Sarcoidosis
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Clinical and subclinical cardiac sarcoidosis (CS) remains diagnostically challenging as the sensitivity and specificity of the diagnostic modalities are limited. The Japanese Ministry of Health and Welfare criteria and the Heart Rhythm Society expert consensus statement on CS are the most common guidelines used to diagnose CS. However, they are mostly based on expert opinions and lack clinical trial validation. The emergence and increase use of newer imaging modalities such as cardiac magnetic resonance and positron emission tomography may give valuable information for accurate diagnosis and assessment of treatment response in CS patient. Although immunosuppressive therapies, particularly corticosteroids, have been proposed as the mainstay of treatment in CS, there is paucity of data on the optimal initiation, duration, and dosage of immunosuppressive therapies. Recommendations are mostly based on small observational studies. Further studies are warranted to better characterize the use of immunosuppressive therapies in this patient population. Device therapies such as implantable cardioverter-defibrillators are usually recommended for patient with clinical CS. In conclusion, this article synthesizes the current best evidence of utilizing various imaging modalities to diagnose CS and summarizing the main therapeutic approaches to manage and treat CS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization
Rybicki, B. A., Major, M., Popovich, J., Maliank, M. J., & lannuzzi, M. C. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009096 · Cited by 1,011
Cited by
Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis
Sève, P., Pacheco, Y., Durupt, F., Jamilloux, Y., Gerfaud-Valentin, M., Isaac, S., Boussel, L., Calender, A., Androdias, G., Valeyre, D., et al. (2021) · Cells · doi:10.3390/cells10040766 · Cited by 487
Transcriptional and Immune Landscape of Cardiac Sarcoidosis
Liu, J., Ma, P., Lai, L., Villanueva, A., Koenig, A., Bean, G. R., Bowles, D. E., Glass, C., Watson, M., Lavine, K. J., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.320449 · Cited by 78
Tan, J. L., Tan, B. E.-X., Cheung, J. W., Ortman, M., & Lee, J. Z. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.04.007 · Cited by 34
Self-citationUccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010150 · Cited by 33
“Regardless of the primary myocardial involvement, as the disease progresses, patients develop HF symptoms and asymptomatic and symptomatic AVB.”
Background
Metadata
- Authors
- Tan, J. L., Fong, H. K., Birati, E. Y., & Han, Y.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 123
- Issue
- 3
- Pages
- 513-522
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W4236684007
- Cited by
- 89
- References
- 1
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiac Sarcoidosis. https://app.cochat.ai/papers/10.1016/j.amjcard.2018.10.021
- The paper
- Tan, J. L., Fong, H. K., Birati, E. Y., & Han, Y. (2019). Cardiac Sarcoidosis. The American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2018.10.021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.